Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lymphoma, Follicular × Mometasone Furoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Apnea, Obstructive 1 Lymphoma, Follicular 1

Interventions

Rituximab 13 Cyclophosphamide 10 fludarabine phosphate 8 Peripheral Blood Stem Cell Transplantation 7 Radiotherapy 5 Whole-Body Irradiation 4 Vincristine 4 Prednisone 4 Lenalidomide 4 Etoposide 4 Doxorubicin 4 Cytarabine 4 Bendamustine Hydrochloride 4 tazemetostat 3 fludarabine 3 Mycophenolic Acid 3 Filgrastim 3 umbralisib 2 ublituximab 2 sargramostim 2 parsaclisib 2 ofatumumab 2 ibritumomab tiuxetan 2 duvelisib 2 Tacrolimus 2 Pentostatin 2 Pentetic Acid 2 Methotrexate 2 Melphalan 2 LFB-R603 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01671852 2015-07-30

Nasonex OSA

Children's & Women's Health Centre of British Columbia

Phase 3 Withdrawn

Lymphoma, Follicular, Sleep Apnea, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡